您好,欢迎来到半岛电竞官方网址 ! [ 登录] [ 免费注册]
半岛电竞官方网址
位置: 首页> 半岛bd体育手机客户端 库> N-Boc-cis-4-Hydroxy-D-proline
立即咨询
咨询类型:
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
N-Boc-cis-4-Hydroxy-D-proline
本半岛bd体育手机客户端 不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
N-Boc-cis-4-Hydroxy-D-proline图片
规格: 98%
分子量: 231.25
包装与价格:
包装 价格(元)
1g 电议
5g 电议

半岛bd体育手机客户端 介绍
N-Boc-cis-4-Hydroxy-D-proline 是不可降解 (non-cleavable) 的 ADC linker,用于合成抗体偶联药物 (ADCs)。N-Boc-cis-4-Hydroxy-D-proline 也是一个基于烷基链 (alkyl chain) 的 PROTAC linker,可用于合成 PROTAC。
货号:ajcx36412
CAS:135042-12-5
分子式:C10H17NO5
分子量:231.25
溶解度:N/A
纯度:98%
存储:Store at -20°C
库存: 现货

Background:

N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-Hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the synth

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].

[1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337.
[2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.

Baidu
map